Tricyclic nucleoside analogues as antiherpes agents

Antiviral Research

Volumn 71, Issue 2-3 SPEC. ISS., 2006, Pages 134-140

  Golankiewicz, Bozenna ^a   Ostrowski, Tomasz ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

Acyclovir; Antivirals; Fluorescence; Ganciclovir; Herpes simplex viruses; Tricyclic analogues

Indexed keywords

3 [[1',2' BIS(HYDROXYMETHYL)CYCLOPROP 1' YL]METHYL]GUANINE; 3,9 DIHYDRO 3 [(1,3 DIHYDROXY 2 PROPOXY)METHYL] 9 OXO 5H IMIDAZO[1,2 A]PURINE; 3,9 DIHYDRO 3 [(2 HYDROXYETHOXY)METHYL] 6 METHYL 9 OXO 5H IMIDAZO[1,2 A]PURINE; 3,9 DIHYDRO 3 [(2 HYDROXYETHOXY)METHYL] 9 OXO 5H IMIDAZO[1,2 A]PURINE; 9 [1,2 BIS(HYDROXYMETHYL)CYCLOPROPYLMETHYL]GUANINE; ACICLOVIR; ACICLOVIR DERIVATIVE; ANTIVIRUS AGENT; GANCICLOVIR; NUCLEOSIDE DERIVATIVE; RA 5021; TRICYCLIC NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DRUG POTENCY; FLUORESCENCE; LIPOPHILICITY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

ACYCLOVIR; ANTIVIRAL AGENTS; FLUORESCENCE; GANCICLOVIR; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

HERPES;

EID: 33747126740     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.05.004     Document Type: Short Survey

References (38)

1. Ashton W.T., Karkas J.D., Field A.K., and Tolman R.L. Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG). Biochem. Biophys. Res. Commun. 108 (1982) 1716-1721
2. Balzarini J., Ostrowski T., Goslinski T., De Clercq E., and Golankiewicz B. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines. Gene Therapy 9 (2002) 1173-1182
3. Beauchamp L.M., Dolmatch B.L., Schaeffer H.J., Collins P., Bauer D.J., Keller P.M., and Fyfe J.A. Modifications on the heterocyclic base of acyclovir: synthesis and antiviral properties. J. Med. Chem. 28 (1985) 982-987
4. Bennett M.S., Wien F., Champness J.N., Batuwangala T., Rutherford T., Summers W.C., Sun H., Wright G., and Sanderson M.R. Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X ray crystallographic comparison with binding of acyclovir. FEBS Lett. 443 (1999) 121-125
5. Boryski J., Golankiewicz B., and De Clercq E. Synthesis and antiviral activity of novel N-substituted derivatives of acyclovir. J. Med. Chem. 31 (1988) 1351-1355
6. Boryski J., Golankiewicz B., and De Clercq E. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir. J. Med. Chem. 34 (1991) 2380-2383
7. Brown D.G., Visse R., Sandhu G., Davies A., Rizkallah P.J., Melitz C., Summers W.C., and Sanderson M.R. Crystal structures of the thymidine kinase from herpes simplex virus type 1 in complex with deoxythymidine and ganciclovir. Nature Struct. Biol. 2 (1995) 876-881
8. Champness J.N., Bennett M.S., Wien F., Visse R., Summers W.C., Herdewijn P., De Clercq E., Ostrowski T., Jarvest R.L., and Sanderson M.R. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with acyclovir and other ligands. Proteins 32 (1998) 350-361
9. Czaplicki J., Bohner T., Habermann A.-K., Folkers G., and Milon A. A transferred NOE study of a tricyclic analog of acyclovir bound to thymidine kinase. J. Biomol. NMR 8 (1996) 261-272
10. De Clercq E., Andrei G., Snoeck R., De Bolle L., Naesens L., Degreve B., Balzarini J., Zhang Y., Schols D., Leyssen P., Ying C., and Neyts J. Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents. Nucleos. Nucleot. Nucleic Acids 20 (2001) 271-285 a review
11. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., and Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5716-5720
12. Elion G.B. The purine pathway to chemotherapy. Science 244 (1989) 41-46 a review
13. Field A.K., Davies M.E., DeWitt C., Perry H.C., Liou R., Germershausen J., Karkas J.D., Ashton W.T., Johnston D.B., and Tolman R.L. 9-{[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl}-guanine: a selective inhibitor of herpes group virus replication. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 4139-4143
14. Field A.K., and Biron K.K. The end of innocence revisited: resistance of herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7 (1994) 1-13
15. Fyfe J.A., Keller P.M., Furman P.A., Miller R.L., and Elion G.B. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253 (1978) 8721-8727
16. Gao H., and Mitra A.K. Synthesis of acyclovir, ganciclovir, and their prodrugs. Synthesis (2000) 329-351 a review
17. Golankiewicz B., Ostrowski T., Boryski J., and De Clercq E. Synthesis of acyclowyosine and acyclo-3-methylguanosine, as probes for some chemical and biological properties resulting from the N-3 substitution of guanosine and its analogues. J. Chem. Soc. Perkin Trans. I (1991) 589-593
18. Golankiewicz B., Ostrowski T., Andrei G., Snoeck R., and De Clercq E. Tricyclic analogues of acyclovir and ganciclovir influence of substituents in the heterocyclic moiety on the antiviral activity. J. Med. Chem. 37 (1994) 3187-3190
19. Golankiewicz B., Ostrowski T., Goslinski T., Januszczyk P., Zeidler J., Baranowski D., and De Clercq E. Fluorescent tricyclic analogues of acyclovir and ganciclovir A structure-antiviral activity study. J. Med. Chem. 44 (2001) 4284-4287
20. Goslinski T., Golankiewicz B., De Clercq E., and Balzarini J. Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir. J. Med. Chem. 45 (2002) 5052-5057
21. Goslinski T., Wenska G., Golankiewicz B., Balzarini J., and De Clercq E. Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir. Nucleos. Nucleot. Nucleic Acids 22 (2003) 911-914
22. Iwayama S., Ono N., Ohmura Y., Suzuki K., Aoki M., Nakazawa H., Oikawa M., Kato T., Okunishi M., Nishiyama Y., and Yamanishi K. Antiherpesvirus activities of (1′S,2′R)-9-{[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in cell culture. Antimicrob. Agents Chemother. 42 (1998) 1666-1670
23. Keller P.M., Fyfe J.A., Beauchamp L., Lubbers C.M., Furman P.A., Schaeffer H.J., and Elion G.B. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol. 30 (1981) 3071-3077
24. Martin J.C., Dvorak C.A., Smee D.F., Matthews T.R., and Verheyden J.P.H. 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. J. Med. Chem. 26 (1983) 759-761
25. Miller W.H., and Miller R.L. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J. Biol. Chem. 255 (1980) 7204-7207
26. Miller W.H., and Miller R.L. Phosphorylation of acyclovir diphosphate by cellular enzymes. Biochem. Pharmacol. 31 (1982) 3879-3884
27. Ogilvie K.K., Cheriyan U.O., Radatus B.K., Smith K.O., Galloway K.S., and Kennell W.L. Biologically active acyclonucleoside and analogues. II. The synthesis of 9-{[2-hydroxyl-1-(hydroxymethyl)ethoxy]methyl}guanine (BIOLF-62). Can. J. Chem. 60 (1982) 3005-3010
28. Ostrowski T., Golankiewicz B., De Clercq E., and Balzarini J. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and gancyclovir analogues. Bioorg. Med. Chem. 13 (2005) 2089-2096
29. Ostrowski T., Golankiewicz B., De Clercq E., and Balzarini J. Synthesis and biological activity of tricyclic analogues of 9-{[cis-1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine. Bioorg. Med. Chem. 14 (2006) 3535-3542
30. Reardon J.E., and Spector T. Herpes simplex virus type 1 DNA polymerase Mechanism of inhibition by acyclovir triphosphate. J. Biol. Chem. 264 (1989) 7405-7411
31. Robins M.J., Hatfield P.W., Balzarini J., and De Clercq E. Nucleic acid related compounds 47. Synthesis and biological activities of pyrimidine and purine "acyclic" nucleoside analogues. J. Med. Chem. 27 (1984) 1486-1492
32. Schaeffer H.J., Beauchamp L., de Miranda P., Elion G.B., Bauer D.J., and Collins P. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 272 (1978) 583-585
33. Sekiyama T., Hatsuya S., Tanaka Y., Uchiyama M., Ono N., Iwayama S., Oikawa M., Suzuki K., Okunishi M., and Tsuji T. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses. J. Med. Chem. 41 (1998) 1284-1298
34. Smith K.O., Galloway K.S., Kennell W.L., Ogilvie K.K., and Radatus B.K. A new nucleoside analog, 9-{[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl}guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 22 (1982) 55-61
35. Suwinska K., Golankiewicz B., and Zielenkiewicz W. Water molecules in the crystal structure of tricyclic acyclovir. Acta Crystallogr. C57 (2001) 767-769
36. Wenska G., Koput J., Insinska-Rak M., Golankiewicz B., Goslinski T., and Ostrowski T. Spectral and photophysical properties of some imidazo[1,2-a]purine derivatives related to acyclovir. J. Photochem. Photobiol., A: Chem. 163 (2004) 171-180
37. 2-(prop-1-ene-1,2-diyl)acyclovir. J. Thermal Anal. 54 (1998) 237-241
38. Zielenkiewicz W., Golankiewicz B., Perlovich G.L., and Kozbial M. Aqueous solubilities, infinite dilution activity coefficients and octanol-water partition coefficients of tricyclic analogs of acyclovir. J. Solution Chem. 28 (1999) 731-745